The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis
Open accessAbstract
Background and aims: Cannabis products with high delta‐9‐tetrahydrocannabinol (THC) concentrations carry an increased risk of addiction and mental health disorders, while it has been suggested that cannabidiol (CBD) may moderate the effects of THC. This study aimed to systematically review and meta‐analyse changes in THC and CBD concentrations in cannabis over time (PROSPERO registration: CRD42019130055). Design: Embase, MEDLINE® and Epub Ahead of Print, In‐Process and Other Non‐Indexed Citations and Daily, Global Health, PsycINFO and Scopus were searched from inception to 27/03/2019 for observational studies reporting changes in mean THC and/or CBD concentration in cannabis over at least three annual time points. Searches and extraction were conducted by two independent reviewers. Random effects meta‐regression models estimated annual changes in THC and CBD for each product within each study; these estimates were pooled across studies in random effects models. Results: We identified 12 eligible studies from the USA, UK, Netherlands, France, Denmark, Italy and New Zealand. For all herbal cannabis, THC concentrations increased by 0.29% each year (95% CI: 0.11, 0.47), P < 0.001 based on 66 747 cannabis samples from eight studies, 1970–2017. For cannabis resin, THC concentrations increased by 0.57% each year (95% CI: 0.10, 1.03), P = 0.017 based on 17 371 samples from eight studies, 1975–2017. There was no evidence for changes in CBD in herbal cannabis [−0.01% (95% CI: −0.02, 0.01), P = 0.280; 49 434 samples from five studies, 1995–2017] or cannabis resin [0.03% (95% CI: −0.11, 0.18), P = 0.651; 11 382 samples from six studies, 1992–2017]. Risk of bias was low apart from non‐random sampling in most studies. There was evidence of moderate to substantial heterogeneity. Conclusions: Concentrations of delta‐9‐tetrahydrocannabinol (THC) in international cannabis markets increased from 1970 to 2017 while cannabidiol (CBD) remained stable. Increases in THC were greater in cannabis resin than herbal cannabis. Rising THC in herbal cannabis was attributable to an increased market share of high‐THC sinsemilla relative to low‐THC traditional herbal cannabis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,178
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Bisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
The heterogeneity statistic I2 can be biased in small meta-analyses
von Hippel, P. T. (2015) · BMC Medical Research Methodology · doi:10.1186/s12874-015-0024-z · Cited by 1,229
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059
Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
Metan: fixed- and random-effects meta-analysis
Harris, R. J., Deeks, J. J., Altman, D. G., Bradburn, M. J., Harbord, R. M., & Sterne, J. A. C. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800102 · Cited by 1,027
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.004 · Cited by 995
Self-citationHarbord, R. M., & Higgins, J. P. T. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800403 · Cited by 897
Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30048-3 · Cited by 875
Self-citationMcGuire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., Taylor, A., & Wright, S. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17030325 · Cited by 617
Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., Bianconi, F., Gardner-Sood, P., O'Connor, J., Russo, M., et al. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00117-5 · Cited by 588
Self-citationMehmedic, Z., Chandra, S., Slade, D., Denham, H., Foster, S., Patel, A. S., Ross, S. A., Khan, I. A., & ElSohly, M. A. (2010) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2010.01441.x · Cited by 475
Self-citationNew trends in cannabis potency in USA and Europe during the last decade (2008–2017)
Chandra, S., Radwan, M. M., Majumdar, C. G., Church, J. C., Freeman, T. P., & ElSohly, M. A. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00983-5 · Cited by 469
Self-citationLower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303818 · Cited by 433
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 389
Self-citationCurran, V., Brignell, C., Fletcher, S., Middleton, P., & Henry, J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1169-0 · Cited by 369
Smart, R., Caulkins, J. P., Kilmer, B., Davenport, S., & Midgette, G. (2017) · Addiction · doi:10.1111/add.13886 · Cited by 369
The Inheritance of Chemical Phenotype in Cannabis sativa L.
de Meijer, E. P. M., Bagatta, M., Carboni, A., Crucitti, P., Moliterni, V. M. C., Ranalli, P., & Mandolino, G. (2003) · Genetics · doi:10.1093/genetics/163.1.335 · Cited by 354
Hurd, Y. L., Spriggs, S., Alishayev, J., Winkel, G., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101191 · Cited by 343
Freeman, T. P., & Winstock, A. R. (2015) · Psychological Medicine · doi:10.1017/s0033291715001178 · Cited by 308
Self-citationMorgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.077503 · Cited by 305
Page, M. J., McKenzie, J. E., & Higgins, J. P. T. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019703 · Cited by 278
Potter, D. J., Clark, P., & Brown, M. B. (2008) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2007.00603.x · Cited by 230
The neuropsychopharmacology of cannabis: A review of human imaging studies
Bloomfield, M. A. P., Hindocha, C., Green, S. F., Wall, M. B., Lees, R., Petrilli, K., Costello, H., Ogunbiyi, M. O., Bossong, M. G., & Freeman, T. P. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.006 · Cited by 230
Self-citationFreeman, A. M., Petrilli, K., Lees, R., Hindocha, C., Mokrysz, C., Curran, H. V., Saunders, R., & Freeman, T. P. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.036 · Cited by 222
Self-citationFreeman, T. P., & Lorenzetti, V. (2020) · Addiction · doi:10.1111/add.14842 · Cited by 221
Self-citationMedicinal use of cannabis based products and cannabinoids
Freeman, T. P., Hindocha, C., Green, S. F., & Bloomfield, M. A. P. (2019) · BMJ · doi:10.1136/bmj.l1141 · Cited by 213
Self-citationAssociation of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence
Hines, L. A., Freeman, T. P., Gage, S. H., Zammit, S., Hickman, M., Cannon, M., Munafo, M., MacLeod, J., & Heron, J. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.1035 · Cited by 208
Self-citationFreeman, T. P., Hindocha, C., Baio, G., Shaban, N. D. C., Thomas, E. M., Astbury, D., Freeman, A. M., Lees, R., Craft, S., Morrison, P. D., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30290-x · Cited by 203
Self-citationTitles versus titles and abstracts for initial screening of articles for systematic reviews
Mateen, F., Oh, Tergas, Bhayani, & Kamdar (2013) · Clinical Epidemiology · doi:10.2147/clep.s43118 · Cited by 202
Cascini, F., Aiello, C., & Tanna, G. D. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205010032 · Cited by 200
Morgan, C. J., Freeman, T. P., Schafer, G. L., & Curran, H. V. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.58 · Cited by 196
Self-citationSolowij, N., Broyd, S., Greenwood, L.-M., van Hell, H., Martelozzo, D., Rueb, K., Todd, J., Liu, Z., Galettis, P., Martin, J., et al. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00978-2 · Cited by 174
Schoedel, K. A., Szeto, I., Setnik, B., Sellers, E. M., Levy-Cooperman, N., Mills, C., Etges, T., & Sommerville, K. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.07.027 · Cited by 169
Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops
Pijlman, F., Rigter, S., Hoek, J., Goldschmidt, H., & Niesink, R. (2005) · Addiction Biology · doi:10.1080/13556210500123217 · Cited by 168
Schoeler, T., Petros, N., Di Forti, M., Klamerus, E., Foglia, E., Ajnakina, O., Gayer-Anderson, C., Colizzi, M., Quattrone, D., Behlke, I., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30188-2 · Cited by 162
Self-citationFreeman, T. P., Morgan, C. J. A., Hindocha, C., Schäfer, G., Das, R., & Curran, H. V. (2014) · Addiction · doi:10.1111/add.12634 · Cited by 149
Self-citationIncreasing potency and price of cannabis in Europe, 2006–16
Freeman, T. P., Groshkova, T., Cunningham, A., Sedefov, R., Griffiths, P., & Lynskey, M. T. (2018) · Addiction · doi:10.1111/add.14525 · Cited by 142
Self-citationvan der Pol, P., Liebregts, N., Brunt, T. M., van Amsterdam, J., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2014) · Addiction · doi:10.1111/add.12508 · Cited by 123
Freeman, T. P., van der Pol, P., Kuijpers, W., Wisselink, J., Das, R., Rigter, S., van Laar, M., Griffiths, P., Swift, W., Niesink, R. J. M., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291717003877 · Cited by 119
Self-citationArterberry, B. J., Treloar Padovano, H., Foster, K. T., Zucker, R. A., & Hicks, B. M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.11.012 · Cited by 103
Big data on a big new market: Insights from Washington State’s legal cannabis market
Caulkins, J. P., Bao, Y., Davenport, S., Fahli, I., Guo, Y., Kinnard, K., Najewicz, M., Renaud, L., & Kilmer, B. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.03.031 · Cited by 99
Niesink, R. J. M., Rigter, S., Koeter, M. W. J., & Brunt, T. M. (2015) · Addiction · doi:10.1111/add.13082 · Cited by 98
Associations between butane hash oil use and cannabis-related problems
Meier, M. H. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.06.015 · Cited by 92
Potter, D. J., Hammond, K. M., Tuffnell, S., Walker, C. J., & Forti, M. D. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2368 · Cited by 92
A study of cannabis potency in France over a 25 years period (1992–2016)
Dujourdy, L., & Besacier, F. (2017) · Forensic Science International · doi:10.1016/j.forsciint.2017.01.007 · Cited by 87
Heterogeneity in the composition of marijuana seized in California
Burgdorf, J. R., Kilmer, B., & Pacula, R. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.031 · Cited by 84
Chouvy, P.-A., & Afsahi, K. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.01.001 · Cited by 68
Cannabis legislation in Europe: an overview.
Guiney, C. (2017) · HRB National Drugs Library (Health Research Board) · Cited by 66
Craft, S., WINSTOCK, A. R., Ferris, J., Mackie, C. J., Lynskey, M. T., & Freeman, T. P. (2019) · Psychological Medicine · doi:10.1017/s0033291719002460 · Cited by 48
Self-citationThomsen, K. R., Lindholst, C., Thylstrup, B., Kvamme, S. L., Reitzel, L. A., Worm‐Leonhard, M., Englund, A., Freeman, T. P., & Hesse, M. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000303 · Cited by 44
Self-citationIs today's marijuana more potent simply because it's fresher?
Sevigny, E. L. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1430 · Cited by 35
Cannabis potency in the Venice area (Italy): Update 2013
Zamengo, L., Frison, G., Bettin, C., et al. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1690 · Cited by 35
The potency of cannabis in New Zealand from 1976 to 1996
Poulsen, H., & Sutherland, G. J. (2000) · Science & Justice · doi:10.1016/s1355-0306(00)71972-1 · Cited by 22
Cited by
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Eichorst, B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s005 · Cited by 305
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Beverly, E. A., Bruemmer, D., Collins, B. S., Darville, A., Ekhlaspour, L., Hassanein, M., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s005 · Cited by 285
Bilbao, A., & Spanagel, R. (2022) · BMC Medicine · doi:10.1186/s12916-022-02459-1 · Cited by 181
Lim, C. C. W., Sun, T., Leung, J., Chung, J. Y. C., Gartner, C., Connor, J., Hall, W., Chiu, V., Stjepanović, D., & Chan, G. C. K. (2022) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2021.4102 · Cited by 107
A social media intervention for cannabis use among emerging adults: randomized controlled trial
Bonar, E. E., Goldstick, J. E., Chapman, L., Bauermeister, J. A., Young, S. D., McAfee, J., & Walton, M. A. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109345 · Cited by 32
Metadata
- Authors
- Freeman, T. P., Craft, S., Wilson, J., Stylianou, S., ElSohly, M., Di Forti, M., & Lynskey, M. T.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2020-11-07
- Volume
- 116
- Issue
- 5
- Pages
- 1000-1010
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W3103481556
- Cited by
- 337
- References
- 57
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.